Inosine

CAS No. 58-63-9

Inosine ( Inosine; NSC 20262; NSC-20262; NSC20262 )

Catalog No. M15159 CAS No. 58-63-9

A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 45 In Stock

Biological Information

  • Product Name
    Inosine
  • Note
    Research use only, not for human use.
  • Brief Description
    A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose.
  • Description
    A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules.
  • Synonyms
    Inosine; NSC 20262; NSC-20262; NSC20262
  • Pathway
    Immunology/Inflammation
  • Target
    ROS
  • Recptor
    XO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58-63-9
  • Formula Weight
    268.23
  • Molecular Formula
    C10H12N4O5
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 47 mg/mL warmed (175.22 mM); DMSO: 53 mg/mL warmed (197.59 mM)
  • SMILES
    OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C(N=CN=C32)O)O1)O)O
  • Chemical Name
    Inosine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Krebs HA, et al. Biochim Biophys Acta, 1953, 12(1-2), 172-180.
molnova catalog
related products
  • Carminic acid

    Carminic acid, the well-known red dyestuff from cochineal insects (Dactylopius spp.), is a potent feeding deterrent to ants.

  • Cyfluthrin

    Cyfluthrin binds to voltage-sensitive sodium channel such as Nav 1.8 sodium channel and modify their gating kinetics, thereby disrupting nerve function of pests.

  • Medicarpin

    Medicarpin a legume phytoalexin acts as an estrogen receptor (ER) agonist can stimulate osteoblast differentiation likely via ERα2 promote achievement of peak bone mass and is devoid of uterine estrogenicity; in addition given its excellent oral bioavailability it can be potential osteogenic agent.